Centogene, a genetic biotech focused on rare diseases, has named Angelos Baxevanis senior vice president communication and marketing.
Baxevanis joins Centogene from AAB Consulting Inc. where he worked with Sobi Pharmaceuticals on projects to enhance commercial capabilities in the rare disease area. He previously led the marketing communication and marketing excellence department at Smith & Nephew, a provider of medical equipment and technology, and was commercial lead at Astra Zeneca.
At Centogene, Baxevanis will be responsible for further developing the company’s marketing and communication strategies, establishing internal marketing workflows, and further positioning it as a leading provider of medical solutions for rare disease patients.
Centogene CEO Arndt Rolfs said that Baxevanis’ “proven track record and combined expertise of marketing and communications in the medical field” will aid the company as it continues its global growth and works to shorten the “diagnostic odyssey” for rare disease patients.